{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:39:27Z","timestamp":1771058367706,"version":"3.50.1"},"publisher-location":"Dordrecht","reference-count":54,"publisher":"Springer Netherlands","isbn-type":[{"value":"9789401771962","type":"print"},{"value":"9789401771979","type":"electronic"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-94-017-7197-9_15","type":"book-chapter","created":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T08:47:24Z","timestamp":1438073244000},"page":"323-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Recombinant Enzyme Replacement Therapy in Hypophosphatasia"],"prefix":"10.1007","author":[{"given":"Christine","family":"Hofmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Jakob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lothar","family":"Seefried","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Mentrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Graser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horacio","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann J.","family":"Girschick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Liese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,29]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s002239900441","volume":"62","author":"DJ Anh","year":"1998","unstructured":"Anh DJ, Dimai HP, Hall SL et al (1998) Skeletal alkaline phosphatase activity is primarily released from human osteoblasts in an insoluble form, and the net release is inhibited by calcium and skeletal growth factors. Calcif Tissue Int 62:332\u2013340","journal-title":"Calcif Tissue Int"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0009-8981(01)00584-8","volume":"311","author":"DJ Anh","year":"2001","unstructured":"Anh DJ, Eden A, Farley JR (2001) Quantitation of soluble and skeletal alkaline phosphatase, and insoluble alkaline phosphatase anchor-hydrolase activities in human serum. Clin Chim Acta 311:137\u2013148","journal-title":"Clin Chim Acta"},{"key":"15_CR3","doi-asserted-by":"crossref","unstructured":"Baumgartner-Sigl S, Haberlandt E, Mumm S et al (2007) Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations. Bone 40(6):1655\u20131661","DOI":"10.1016\/j.bone.2007.01.020"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1210\/jc.2006-2131","volume":"92","author":"RA Cahill","year":"2007","unstructured":"Cahill RA, Wenkert D, Perlman SA et al (2007) Infantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblasts. J Clin Endocrinol Metab 92:2923\u20132930","journal-title":"J Clin Endocrinol Metab"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4158\/EP.14.2.204","volume":"14","author":"PM Camacho","year":"2008","unstructured":"Camacho PM, Painter S, Kadanoff R (2008) Treatment of adult hypophosphatasia with teriparatide. Endocr Pract 14:204\u2013208","journal-title":"Endocr Pract"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00381-008-0708-3","volume":"25","author":"H Collmann","year":"2009","unstructured":"Collmann H, Mornet E, Gattenlohner S et al (2009) Neurosurgical aspects of childhood hypophosphatasia. Childs Nerv Syst 25:217\u2013223","journal-title":"Childs Nerv Syst"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s00381-004-1116-y","volume":"21","author":"H Collmann","year":"2005","unstructured":"Collmann H, Sorensen N, Krauss J (2005) Hydrocephalus in craniosynostosis: a review. Childs Nerv Syst 21:902\u2013912","journal-title":"Childs Nerv Syst"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1542\/peds.2007-3847","volume":"123","author":"LA Clarke","year":"2009","unstructured":"Clarke LA, Wraith JE, Beck M et al (2009) Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I. Pediatrics 123:229\u2013240","journal-title":"Pediatrics"},{"key":"15_CR9","first-page":"1045","volume":"23","author":"C Deduve","year":"1964","unstructured":"Deduve C (1964) From Cytases to Lysosomes. Fed Proc 23:1045\u20131049","journal-title":"Fed Proc"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-genom-090711-163739","volume":"13","author":"RJ Desnick","year":"2012","unstructured":"Desnick RJ, Schuchman EH (2012) Enzyme replacement therapy for lysosomal diseases: lessons from 20\u00a0years of experience and remaining challenges. Annu Rev Genomics Hum Genet 13:307\u2013335","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"15_CR11","first-page":"266","volume":"6","author":"KB Doshi","year":"2009","unstructured":"Doshi KB, Hamrahian AH, Licata AA (2009) Teriparatide treatment in adult hypophosphatasia in a patient exposed to bisphosphonate: a case report. Clin Cases Miner Bone Metab 6:266\u2013269","journal-title":"Clin Cases Miner Bone Metab"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1359\/jbmr.1999.14.12.2015","volume":"14","author":"KN Fedde","year":"1999","unstructured":"Fedde KN, Blair L, Silverstein J et al (1999) Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 14:2015\u20132026","journal-title":"J Bone Miner Res"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/0003-9861(88)90305-0","volume":"264","author":"KN Fedde","year":"1988","unstructured":"Fedde KN, Lane CC, Whyte MP (1988) Alkaline phosphatase is an that acts on micromolar concentrations of natural substrates at physiologic pH in human osteosarcoma (SAOS-2) cells. Arch Biochem Biophys 264:400\u2013409","journal-title":"Arch Biochem Biophys"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","volume":"122","author":"GA Grabowski","year":"1995","unstructured":"Grabowski GA, Barton NW, Pastores G et al (1995) Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Ann Intern Med 122:33\u201339","journal-title":"Ann Intern Med"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","volume":"148","author":"P Harmatz","year":"2006","unstructured":"Harmatz P, Giugliani R, Schwartz I et al (2006) Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo- controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. J Pediatr 148:533\u2013539","journal-title":"J Pediatr"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"9445","DOI":"10.1073\/pnas.142063399","volume":"99","author":"L Hessle","year":"2002","unstructured":"Hessle L, Johnson KA, Anderson HC et al (2002) Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA 99:9445\u20139449","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12018-013-9139-0","volume":"11","author":"C Hofmann","year":"2013","unstructured":"Hofmann C, Girschick H, Mentrup B et al (2013) Clinical aspects of hypophosphatasia: an update. Clin Rev Bone Miner Metab 11:60\u201370","journal-title":"Clin Rev Bone Miner Metab"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0009-8981(97)00161-7","volume":"266","author":"NM Hooper","year":"1997","unstructured":"Hooper NM (1997) Glycosyl-phosphatidylinositol anchored membrane enzymes. Clin Chim Acta 266:3\u201312","journal-title":"Clin Chim Acta"},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1086\/316953","volume":"68","author":"YA Ioannou","year":"2001","unstructured":"Ioannou YA, Zeidner KM, Gordon RE et al (2001) Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase a replacement in enzyme-deficient mice. Am J Hum Genet 68:14\u201325","journal-title":"Am J Hum Genet"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/jb\/mvg114","volume":"134","author":"Y Ishida","year":"2003","unstructured":"Ishida Y, Komaru K, Ito M et al (2003) Tissue-nonspecific alkaline phosphatase with an Asp(289)\u2013>Val mutation fails to reach the cell surface and undergoes proteasome-mediated degradation. J Biochem 134:63\u201370","journal-title":"J Biochem"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.spen.2007.08.008","volume":"14","author":"V Kimonis","year":"2007","unstructured":"Kimonis V, Gold JA, Hoffman TL et al (2007) Genetics of craniosynostosis. Semin Pediatr Neurol 14:150\u2013161","journal-title":"Semin Pediatr Neurol"},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/jbmr.1733","volume":"28","author":"T Kiffer-Moreira","year":"2013","unstructured":"Kiffer-Moreira T, Yadav MC, Zhu D et al (2013) Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification. J Bone Miner Res 28:81\u201391","journal-title":"J Bone Miner Res"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/8904_2013_224","volume":"11","author":"EC Leung","year":"2013","unstructured":"Leung EC, Mhanni AA, Reed M et al (2013) Outcome of perinatal hypophosphatasia in manitoba mennonites: a retrospective cohort analysis. JIMD Rep 11:73\u201378","journal-title":"JIMD Rep"},{"key":"15_CR24","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/ki.2008.26","volume":"73","author":"KA Lomashvili","year":"2008","unstructured":"Lomashvili KA, Garg P, Narisawa S et al (2008) Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification. Kidney Int 73:1024\u20131030","journal-title":"Kidney Int"},{"key":"15_CR25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/0022034510393517","volume":"90","author":"MD McKee","year":"2011","unstructured":"McKee MD, Nakano Y, Masica DL et al (2011) Enzyme replacement therapy prevents dental defects in a model of hypophosphatasia. J Dent Res 90:470\u2013476","journal-title":"J Dent Res"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.bone.2011.03.676","volume":"48","author":"B Mentrup","year":"2011","unstructured":"Mentrup B, Marschall C, Barvencik F et al (2011) Functional characterization of a novel mutation localized in the start codon of the tissue-nonspecific alkaline phosphatase gene. Bone 48:1401\u20131408","journal-title":"Bone"},{"issue":"4","key":"15_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00223-012-9672-8","volume":"93","author":"JL Millan","year":"2013","unstructured":"Millan JL (2013) The role of phosphatases in the initiation of skeletal mineralization. Calcif Tissue Int 93(4):299\u2013306","journal-title":"Calcif Tissue Int"},{"key":"15_CR28","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1359\/jbmr.071213","volume":"23","author":"JL Millan","year":"2008","unstructured":"Millan JL, Narisawa S, Lemire I et al (2008) Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res 23:777\u2013787","journal-title":"J Bone Miner Res"},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1096\/fj.00-0014com","volume":"14","author":"SR Miranda","year":"2000","unstructured":"Miranda SR, He X, Simonaro CM et al (2000) Infusion of recombinant human acid sphingomyelinase into niemann-pick disease mice leads to visceral, but not neurological, correction of the pathophysiology. FASEB J 14:1988\u20131995","journal-title":"FASEB J"},{"key":"15_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2013.177","author":"E Mornet","year":"2013","unstructured":"Mornet E, Hofmann C, Bloch-Zupan A et al (2013) Clinical utility gene card for: hypophosphatasia \u2013 update. Eur J Hum Genet. doi:10.1038\/ejhg.2013.177","journal-title":"Eur J Hum Genet"},{"key":"15_CR31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ymgme.2006.09.001","volume":"90","author":"J Muenzer","year":"2007","unstructured":"Muenzer J, Gucsavas-Calikoglu M, McCandless SE et al (2007) A phase I\/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). Mol Genet Metab 90:329\u2013337","journal-title":"Mol Genet Metab"},{"key":"15_CR32","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1097\/01.PRS.0000122202.26792.BF","volume":"113","author":"JB Mulliken","year":"2004","unstructured":"Mulliken JB, Gripp KW, Stolle CA et al (2004) Molecular analysis of patients with synostotic frontal plagiocephaly (unilateral coronal synostosis). Plast Reconstr Surg 113:1899\u20131909","journal-title":"Plast Reconstr Surg"},{"key":"15_CR33","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/(SICI)1097-0177(199703)208:3<432::AID-AJA13>3.0.CO;2-1","volume":"208","author":"S Narisawa","year":"1997","unstructured":"Narisawa S, Frohlander N, Millan JL (1997) Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dyn 208:432\u2013446","journal-title":"Dev Dyn"},{"key":"15_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH722>3.0.CO;2-Y","volume":"193","author":"S Narisawa","year":"2001","unstructured":"Narisawa S, Wennberg C, Millan JL (2001) Abnormal vitamin B6 metabolism in alkaline phosphatase knock-out mice causes multiple abnormalities, but not the impaired bone mineralization. J Pathol 193:125\u2013133","journal-title":"J Pathol"},{"key":"15_CR35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ymgme.2006.02.012","volume":"88","author":"T Nishioka","year":"2006","unstructured":"Nishioka T, Tomatsu S, Gutierrez MA et al (2006) Enhancement of drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide. Mol Genet Metab 88:244\u2013255","journal-title":"Mol Genet Metab"},{"key":"15_CR36","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1359\/jbmr.070714","volume":"22","author":"S Narisawa","year":"2007","unstructured":"Narisawa S, Harmey D, Yadav MC et al (2007) Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification. J Bone Miner Res 22:1700\u20131710","journal-title":"J Bone Miner Res"},{"key":"15_CR37","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/ppul.22527","volume":"47","author":"E Rodriguez","year":"2012","unstructured":"Rodriguez E, Bober MB, Davey L et al (2012) Respiratory mechanics in an infant with perinatal lethal hypophosphatasia treated with human recombinant enzyme replacement therapy. Pediatr Pulmonol 47:917\u2013922","journal-title":"Pediatr Pulmonol"},{"key":"15_CR38","doi-asserted-by":"publisher","first-page":"43160","DOI":"10.1074\/jbc.M107778200","volume":"276","author":"MS Sands","year":"2001","unstructured":"Sands MS, Vogler CA, Ohlemiller KK et al (2001) Biodistribution, kinetics, and efficacy of highly phosphorylated and non-phosphorylated beta-glucuronidase in the murine model of mucopolysaccharidosis VII. J Biol Chem 276:43160\u201343165","journal-title":"J Biol Chem"},{"key":"15_CR39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/adc.65.1.130","volume":"65","author":"SS Seshia","year":"1990","unstructured":"Seshia SS, Derbyshire G, Haworth JC et al (1990) Myopathy with hypophosphatasia. Arch Dis Child 65:130\u2013131","journal-title":"Arch Dis Child"},{"key":"15_CR40","doi-asserted-by":"publisher","first-page":"170e","DOI":"10.1097\/01.prs.0000304441.99483.97","volume":"121","author":"BJ Slater","year":"2008","unstructured":"Slater BJ, Lenton KA, Kwan MD et al (2008) Cranial sutures: a brief review. Plast Reconstr Surg 121:170e\u2013178e","journal-title":"Plast Reconstr Surg"},{"key":"15_CR41","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/jbmr.1565","volume":"27","author":"RA Sutton","year":"2012","unstructured":"Sutton RA, Mumm S, Coburn SP et al (2012) \u201cAtypical femoral fractures\u201d during bisphosphonate exposure in adult hypophosphatasia. J Bone Miner Res 27:987\u2013994","journal-title":"J Bone Miner Res"},{"key":"15_CR42","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jpeds.2008.12.021","volume":"154","author":"M Tadokoro","year":"2009","unstructured":"Tadokoro M, Kanai R, Taketani T et al (2009) New bone formation by allogeneic mesenchymal stem cell transplantation in a patient with perinatal hypophosphatasia. J Pediatr 154:924\u2013930","journal-title":"J Pediatr"},{"key":"15_CR43","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/tropej\/46.3.132","volume":"46","author":"TD Thacher","year":"2000","unstructured":"Thacher TD, Fischer PR, Pettifor JM et al (2000) Radiographic scoring method for the assessment of the severity of nutritional rickets. J Trop Pediatr 46:132\u2013139","journal-title":"J Trop Pediatr"},{"key":"15_CR44","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1161\/CIRCRESAHA.110.234419","volume":"108","author":"DA Towler","year":"2011","unstructured":"Towler DA, Demer LL (2011) Thematic series on the pathobiology of vascular calcification: an introduction. Circ Res 108:1378\u20131380","journal-title":"Circ Res"},{"key":"15_CR45","doi-asserted-by":"publisher","first-page":"H61","DOI":"10.1152\/ajpheart.01020.2010","volume":"301","author":"R Villa-Bellosta","year":"2011","unstructured":"Villa-Bellosta R, Wang X, Millan JL et al (2011) Extracellular pyrophosphate metabolism and calcification in vascular smooth muscle. Am J Physiol Heart Circ Physiol 301:H61\u2013H68","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"15_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ng0995-45","volume":"11","author":"KG Waymire","year":"1995","unstructured":"Waymire KG, Mahuren JD, Jaje JM et al (1995) Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat Genet 11:45\u201351","journal-title":"Nat Genet"},{"key":"15_CR47","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1651-2227.1989.tb11297.x","volume":"360","author":"M Weninger","year":"1989","unstructured":"Weninger M, Stinson RA, Plenk H et al (1989) Biochemical and morphological effects of human hepatic alkaline phosphatase in a neonate with hypophosphatasia. Acta Paediatr Scand Suppl 360:154\u2013160","journal-title":"Acta Paediatr Scand Suppl"},{"key":"15_CR48","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1749-6632.2010.05387.x","volume":"1192","author":"MP Whyte","year":"2010","unstructured":"Whyte MP (2010) Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann N Y Acad Sci 1192:190\u2013200","journal-title":"Ann N Y Acad Sci"},{"key":"15_CR49","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1106173","volume":"366","author":"MP Whyte","year":"2012","unstructured":"Whyte MP, Greenberg CR, Salman NJ et al (2012) Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med 366:904\u2013913","journal-title":"N Engl J Med"},{"key":"15_CR50","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1359\/jbmr.2003.18.4.624","volume":"18","author":"MP Whyte","year":"2003","unstructured":"Whyte MP, Kurtzberg J, McAlister WH et al (2003) Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res 18:624\u2013636","journal-title":"J Bone Miner Res"},{"key":"15_CR51","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0022-3476(84)80079-7","volume":"105","author":"MP Whyte","year":"1984","unstructured":"Whyte MP, McAlister WH, Patton LS et al (1984) Enzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphatase-rich Paget plasma: results in three additional patients. J Pediatr 105:926\u2013933","journal-title":"J Pediatr"},{"key":"15_CR52","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1210\/jc.2006-1902","volume":"92","author":"MP Whyte","year":"2007","unstructured":"Whyte MP, Mumm S, Deal C (2007) Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab 92:1203\u20131208","journal-title":"J Clin Endocrinol Metab"},{"key":"15_CR53","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0022-3476(82)80061-9","volume":"101","author":"MP Whyte","year":"1982","unstructured":"Whyte MP, Valdes R Jr, Ryan LM et al (1982) Infantile hypophosphatasia: enzyme replacement therapy by intravenous infusion of alkaline phosphatase-rich plasma from patients with Paget bone disease. J Pediatr 101:379\u2013386","journal-title":"J Pediatr"},{"key":"15_CR54","doi-asserted-by":"publisher","first-page":"e19595","DOI":"10.1371\/journal.pone.0019595","volume":"6","author":"D Zhu","year":"2011","unstructured":"Zhu D, Mackenzie NC, Millan JL et al (2011) The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS One 6:e19595","journal-title":"PLoS One"}],"container-title":["Subcellular Biochemistry","Neuronal Tissue-Nonspecific Alkaline Phosphatase (TNAP)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-017-7197-9_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T08:40:17Z","timestamp":1676968817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-017-7197-9_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9789401771962","9789401771979"],"references-count":54,"URL":"https:\/\/doi.org\/10.1007\/978-94-017-7197-9_15","relation":{},"ISSN":["0306-0225"],"issn-type":[{"value":"0306-0225","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]},"assertion":[{"value":"29 July 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}